The risk of ovulation increases with each day beyond the recommended contraceptive-free period. A non-hormonal contraceptive must then be used concurrently for 7 days. If there are more than 7 transdermal patch-free days, the user may not be protected against pregnancy. Under no circumstances should there be more than a 7-day transdermal patch-free interval between dosing cycles. The fourth week is transdermal patch-free starting on Day 22.Ī new contraceptive cycle begins on the next day following transdermal patch-free week the next EVRA transdermal patch should be applied even if there has been no withdrawal bleeding or if withdrawal bleeding has not yet stopped. Transdermal patch changes may occur at any time on the scheduled Change Day. Only one transdermal patch is to be worn at a time.Įach used transdermal patch is removed and immediately replaced with a new one on the same day of the week (Change Day) on Day 8 and Day 15 of the cycle. For initiation instructions see 'How to start EVRA' below. To achieve maximum contraceptive effectiveness, patients must be advised to use EVRA exactly as directed.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |